102 related articles for article (PubMed ID: 20385414)
1. Chemoreirradiation for recurrent salivary gland malignancies.
Pederson AW; Haraf DJ; Blair EA; Stenson KM; Witt ME; Vokes EE; Salama JK
Radiother Oncol; 2010 Jun; 95(3):308-11. PubMed ID: 20385414
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
Rosenberg L; Weissler M; Hayes DN; Shockley W; Zanation A; Rosenman J; Chera B
Head Neck; 2012 Jun; 34(6):872-6. PubMed ID: 22127998
[TBL] [Abstract][Full Text] [Related]
5. Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull.
Lee N; Millender LE; Larson DA; Wara WM; McDermott MW; Kaplan MJ; Sneed PK
Head Neck; 2003 Mar; 25(3):210-6. PubMed ID: 12599288
[TBL] [Abstract][Full Text] [Related]
6. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
8. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
[TBL] [Abstract][Full Text] [Related]
12. Malignant minor salivary gland tumors of the larynx.
Ganly I; Patel SG; Coleman M; Ghossein R; Carlson D; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):767-70. PubMed ID: 16847187
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.
Tanvetyanon T; Qin D; Padhya T; McCaffrey J; Zhu W; Boulware D; DeConti R; Trotti A
Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):687-92. PubMed ID: 19620591
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and carboplatin for recurrent salivary gland malignancies.
Airoldi M; Fornari G; Pedani F; Marchionatti S; Gabriele P; Succo G; Bumma C
Anticancer Res; 2000; 20(5C):3781-3. PubMed ID: 11268454
[TBL] [Abstract][Full Text] [Related]
15. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience.
Aro K; Leivo I; Mäkitie AA
Laryngoscope; 2008 Feb; 118(2):258-62. PubMed ID: 18030166
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Cohen EE; Rosine D; Haraf DJ; Loh E; Shen L; Lusinchi A; Vokes EE; Bourhis J
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):678-84. PubMed ID: 17293229
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
18. [Results of radiation therapy of carcinoma of the salivary glands].
Horiuchi J; Shibuya H; Takeda M; Suzuki S
Gan No Rinsho; 1986 Feb; 32(2):117-22. PubMed ID: 3959334
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for patients of malignant salivary gland tumors with positive surgical margins.
Sakata K; Aoki Y; Karasawa K; Nakagawa K; Hasezawa K; Muta N; Terahara A; Onogi Y; Sasaki Y; Akanuma A
Strahlenther Onkol; 1994 Jun; 170(6):342-6. PubMed ID: 8023243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
